About us
Services & Solutions
Chemistry DMPK Discovery Biology Oncology Pharmacology Biologics
Medicinal Chemistry Computational Chemistry Synthetic Chemistry Analytical Chemistry Scale Up Chemistry
In Vivo PK and TK In Vitro ADME Bioanalytical Service Exploratory Toxicity In Rodents, Dogs and Monkeys Large Molecules Capabilities Bioanalytical Instruments
Biochemical Assays Cellular Assays Protein Science Assay Technologies Biophysics SPR Safety Pharmacology Screening Services Key Instruments
PDX CDX Orthotopic Models Syngeneic Models Humanized Mouse Models CAR-T and CAR-NK Mouse Models In Vitro Assays
Immunology Inflammation Metabolic NASH Respiratory Neuroscience
Systematic Antibody Discovery Service
Process R&D Scale Up Synthesis DS Manufacturing
Flow Chemistry Sugar Chemistry Peptide Chemistry Preparative Purification Capacity Process Safety Assessment
Synthetic and Scale Up Chemistry Parallel Synthesis
Flow Chemistry Kilo and Pilot Scale Production RSM and Intermediates Manufacturing QA EHS
Pre-Formulation Formulation, Analytical and Process Development Drug Product Manufacturing
Bioavailability Enhancement Modified Release
Commercial Manufacturing
Platforms
News & Resources
Careers
Contact us
CN EN
×
news
Company News Events Insights Webinars Virtual Tours
Sundia and UChem Exhibit in the 20th Korea Organic Synthetic Society Conference
Shanghai, November 21, 2019 – November 13-15,Sundia and UChem exhibited in the 20th Korea Organic Synthetic Society Conference in Yongin, Korea. Over 200 professors and researchers attended the conference. Sundia is proudly
November 21, 2019
BioDuro Launches New Antibody & Cell Therapy Discovery Services
SAN DIEGO,November 20, 2019 – (BUSINESS WIRE)–BioDuro, LLC, a leading global life sciences contract research and development organization, announced today that it has broadly launched new antibody- and cell-based th
November 20, 2019
BioDuro Welcomes New Chief Financial Officer
SAN DIEGO, June 30, 2019 – (BUSINESS WIRE)–BioDuro, LLC, a leading global life sciences contract research, development and manufacturing services organization, announced today the appointment of Jeffery Blazevich as t
June 30, 2019
Congratulations to Sinovent for NMPA IND approval
Shanghai, May 24, 2019 – Congratulations to Sinovent for their Class 1 new drug XNW7201 and tablets (CXHL1900110, CXHL1900111, CXHL1900112, CXHL1900113) received NMPA IND approval. XNW7201 is an inhibitor for the Wnt pat
May 24, 2019
Session conference—BioKorea
Shanghai, April 18, 2019 – Sundia will hold a session conference with Oscotec Inc. Bridge Biotherapeutics, Inc. and U-Chem at BioKorea in the morning of April 18th, 2019. We invited Dr. Jung-Ho Kim ,(Executive Director, CTO)of
April 18, 2019
Total 84 12...891011121314...1617
Subscribe to BioDuro-Sundia
Receive our newsletter and information on upcoming events
Your trusted partner from drug discovery and
development to commercialization

Home

About us

Services & Solutions

Platforms

News & Resources

Careers

Contact us

Explore

Discovery

Drug Substance

Drug Product

© 2023 BioDuro-Sundia. All rights reserved
Terms of Use Privacy Policy
We use necessary cookies to ensure our website functions properly and to keep it secure. These necessary cookies must be enabled. By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. You can personalize or withdraw your consent at any moment by clicking on the link "Cookies Settings". For more information on how we use cookies, including the total lifespan of cookies and the identity of third parties intervening on our website, please consult the Privacy Notice available in the site footer.
Accept all